Work

Phase Ib/2 study of venetoclax with low-dose cytarabine in treatment-naive patients age ≥ 65 with acute myelogenous leukemia.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.7007

Authors: Tara L. Lin, Stephen Anthony Strickland, Walter Fiedler, Roland B. Walter, Jing-Zhou Hou, Gail J. Roboz, Anoop Enjeti, Kaffa Mussumeh Fakhoui, David E Darden, Martin Dunbar, Ming Zhu, John W. Hayslip, Andrew H. Wei

Institutions: University of Kansas Medical Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center, University Medical Center Hamburg-Eppendorf, University Cancer Center Hamburg, University of Washington, Fred Hutch Cancer Center, University of Pittsburgh Medical Center, Weill Cornell Medicine, Calvary Mater Newcastle Hospital, University of Newcastle Australia, AbbVie (United States), The Alfred Hospital, Monash University

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2726229796

Cites:

Cited by: 36

Related to: 10